Effect of blood collection tubes on total triiodothyronine and other laboratory assays

被引:63
作者
Bowen, RAR [1 ]
Chan, Y [1 ]
Cohen, J [1 ]
Rehak, NN [1 ]
Hortin, GL [1 ]
Csako, G [1 ]
Remaley, AT [1 ]
机构
[1] NIH, Clin Chem Serv, Dept Lab Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA
关键词
D O I
10.1373/clinchem.2004.043349
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Increased total triiodothyronine (TT3) assay results in apparently euthyroid patients triggered an investigation of the effect of blood collection tubes on serum TT3 and other laboratory assays. Methods: We examined potential assay interference for three types of tubes: plastic Greiner Bio-One(TM) Vacuette(TM); glass Becton Dickinson (BD) Vacutainer(TM); and plastic BD Vacutainer SST(TM) tubes. Serum samples from apparently healthy volunteers (age range, 30-60 years; 15 males and 34 females) were collected in different tube types and analyzed in 17 immunoassays (n = 49), 30 clinical chemistry tests (n = 20), and 33 immunology assays (n = 15). Tube effects were also examined by adding pooled serum to different tube types. Results: TT3 values, when measured by the IMMULITE(TM) 2000 but not the AxSYM(TM) analyzer, were significantly higher (P < 0.0001) for SST (2.81 nmol/L) than either glass (2.15 nmol/L) or Vacuette (2.24 nmol/L) tubes. The effect was large enough to substantially shift the distribution of patient values, increasing the percentage of values above the reference interval from 11.3% to 35.8%. The degree of interference from SST tubes on TT3 differed among various tube lots and could be attributed to a tube additive shared by other plastic tubes. Results from several other tests statistically differed among tube types, but differences we're not considered to be clinically significant. Conclusions: Assay interferences from blood collection tubes represent challenges to clinical laboratories because they are not detected by the usual quality-control or proficiency testing programs. Laboratories can, however, address this problem by monitoring distribution of patients' results. (C) 2005 American Association for Clinical Chemistry.
引用
收藏
页码:424 / 433
页数:10
相关论文
共 30 条
[1]  
Anraku H., 1989, United States patent, Patent No. [4856533A, 4856533]
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   Evaluation of a new generation of plastic evacuated blood-collection tubes in clinical chemistry, therapeutic drug monitoring, hormone and trace metal analysis [J].
Boeynaems, JM ;
De Leener, A ;
Dessars, B ;
Villa-Lobos, HR ;
Aubry, JC ;
Cotton, F ;
Thiry, P .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (01) :67-71
[4]  
Boyanton BL, 2002, CLIN CHEM, V48, P2242
[5]   Stability of therapeutic drugs in serum collected in vacutainer serum separator tubes containing a new gel (SST II) [J].
Bush, V ;
Blennerhasset, J ;
Wells, A ;
Dasgupta, A .
THERAPEUTIC DRUG MONITORING, 2001, 23 (03) :259-262
[6]   Comparison of BD Vacutainer SST™ Plus Tubes with BD SST™ II Plus Tubes for common analytes [J].
Bush, VJ ;
Janu, MR ;
Bathur, F ;
Wells, A ;
Dasgupta, A .
CLINICA CHIMICA ACTA, 2001, 306 (1-2) :139-143
[7]   Evaluation of AVL988/4 analyzer for measurement of ionized magnesium and ionized calcium [J].
Cao, Z ;
Tongate, C ;
Elin, RJ .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2001, 61 (05) :389-394
[8]  
Cembrowski GS, 1997, CLIN CHEM, V43, P886
[9]   Stability of therapeutic drug measurement in specimens collected in VACUTAINER plastic blood-collection tubes [J].
Dasgupta, A ;
Blackwell, W ;
Bard, D .
THERAPEUTIC DRUG MONITORING, 1996, 18 (03) :306-309
[10]  
DASGUPTA A, 1994, AM J CLIN PATHOL, V101, P456